USP works in cooperation with diverse organizations around the world.
USP advances the quality, safety and benefit of medicines and foods across the globe through international policy and regulatory analysis, advocacy, and collaboration with governments, multilateral institutions, regional cooperation initiatives and other stakeholder organizations.
USP standards build public trust in medicines, and are an important resource in the medicine supply chain safety net to ensure safe, quality medicines reach patients.
Antimicrobial resistance (AMR) causes an estimated 700,000 deaths annually worldwide, and every country is potentially affected. If not properly addressed, the number could grow to 10 million per year by 2050.
USP joined the 144th Session of WHO's Executive Board Meeting to lend our voice highlighting medicines quality across global health agendas. Read USP's Statements on: